New York University- Langone Health — New York, New York

New York University- Langone Health is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

New York University- Langone Health has participated in 1 clinical trials.

Therapeutic areas: Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IIIB Prostate Cancer AJCC v8.

Sponsors: Thomas Jefferson University.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University- Langone Health?

New York University- Langone Health has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University- Langone Health conducted?

New York University- Langone Health has 1 clinical trials on record. Their work covers Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IIIB Prostate Cancer AJCC v8.

Is New York University- Langone Health accredited by Crixeo Health?

New York University- Langone Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York University- Langone Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.